Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Article Category

Content archived on 2024-03-25

Article available in the following languages:

EN

DIGI-B-CUBE Open Call to support SMEs - final deadline

After a successful first phase which gathered 217 applications from a total of 470 SMEs based in 34 countries, including European Union Member States and Horizon 2020 associated countries, the project is inviting applications for the second and final phase, to provide Prototyping and Customised Solution Innovation vouchers. The final deadline is February 3, 2021.

DIGI-B-CUBE project launched an open call for funding in 2020, to support projects focusing on integrating digital innovations and disruptive technologies across the Medical Diagnostics and related value chains. Small and Medium Enterprises (including new start-ups) operating in the health, medicine, biotech, biopharma, IT or related sectors (robotics, automation, electronics, nanotech, etc.) can apply for equity-free funding up to €60,000 through the DIGI-B-CUBE voucher scheme. After a successful first phase which gathered 217 applications from a total of 470 SMEs based in 34 countries, including European Union Member States and Horizon 2020 associated countries, the project is inviting applications for the second and final phase, to provide Prototyping and Customised Solution Innovation vouchers. The final deadline is February 3, 2021. APPLY HERE: https://digibcube.eu/open-calls/  ABOUT DIGI-B-CUBE project The DIGI-B-CUBE project aims to unlock the cross-sectoral collaborative potential of SMEs by combining Artificial Intelligence (AI), Cognitive Computing Digital Technologies (CCDT) with the Bioimaging-Biosensing-Biobanking (B-CUBE) industries to deliver market sensitive disruptive technologies and generating innovative solutions that enhance patient-centred diagnostic work-flows, delivered through the improved algorithms for Medical Diagnostics’ efficiency and accuracy. By integrating innovations in IT into Bioimaging, Biosensing and Biobanking industries, this project will accelerate the goal of personalised medicine that can eventually offer patients with a fast and efficient diagnosis-treatment-healthcare system. Digital innovations will reconfigure how health treatment is provided and will lead to more effective diagnosis and will enable precision medicine.

Related articles